YEAR
- 2012.05.20 Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. Negishi H, Yanai H, Nakajima A, Koshiba R, Atarashi K, Matsuda A, Matsuki K, Miki S, Doi T, Aderem A, Nishio J, Smale ST, Honda K, Taniguchi T.Nat. Immunol. 2012 May 20;13(7):659-66. doi: 10.1038/ni.2307
- 2012.05.25 Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas. Shoji K, Oda K, Kashiyama T, Ikeda Y, Nakagawa S, Sone K, Miyamoto Y, Hiraike H, Tanikawa M, Miyasaka A, Koso T, Matsumoto Y, Wada-Hiraike O, Kawana K, Kuramoto H, McCormick F, Aburatani H, Yano T, Kozuma S, Taketani Y.PLoS ONE. 2012;7(5):e37431. doi: 10.1371/journal.pone.0037431
- 2012.05.29 Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A. Mimura I, Nangaku M, Kanki Y, Tsutsumi S, Inoue T, Kohro T, Yamamoto S, Fujita T, Shimamura T, Suehiro J, Taguchi A, Kobayashi M, Tanimura K, Inagaki T, Tanaka T, Hamakubo T, Sakai J, Aburatani H, Kodama T, Wada Y.Mol. Cell. Biol. 2012 Aug;32(15):3018-32. doi: 10.1128/MCB.06643-11
- 2012.05.29 Potential role of LMP2 as an anti-oncogenic factor in human uterine leiomyosarcoma: morphological significance of calponin h1. Hayashi T, Horiuchi A, Sano K, Hiraoka N, Kasai M, Ichimura T, Sudo T, Nishimura R, Ishiko O, Shiozawa T, Kanai Y, Yaegashi N, Aburatani H, Konishi I.FEBS Lett. 2012 Jun 21;586(13):1824-31. doi: 10.1016/j.febslet.2012.05.029
- 2012.06.06 Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Yae T, Tsuchihashi K, Ishimoto T, Motohara T, Yoshikawa M, Yoshida GJ, Wada T, Masuko T, Mogushi K, Tanaka H, Osawa T, Kanki Y, Minami T, Aburatani H, Ohmura M, Kubo A, Suematsu M, Takahashi K, Saya H, Nagano O.Nat Commun. 2012 Jun 06;3:883. doi: 10.1038/ncomms1892
- 2012.06.07 Structural and thermodynamic characterization of the self-adhesive properties of human P-cadherin. Kudo S, Caaveiro JM, Miyafusa T, Goda S, Ishii K, Matsuura T, Sudou Y, Kodama T, Hamakubo T, Tsumoto K.Mol Biosyst. 2012 Aug;8(8):2050-3. doi: 10.1039/c2mb25161b
- 2012.07.03 Epstein-Barr virus infection as an epigenetic driver of tumorigenesis. Kaneda A, Matsusaka K, Aburatani H, Fukayama M.Cancer Res. 2012 Jul 15;72(14):3445-50. doi: 10.1158/0008-5472.CAN-11-3919
- 2012.07.10 Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, Yamamoto M, Motohashi H.Cancer Cell. 2012 Jul 10;22(1):66-79. doi: 10.1016/j.ccr.2012.05.016
CLOSE